Chinmax Defends its Distribution Rights to Biosite Triage Products, Filing Suit in China against Subsidiary of Inverness Medical Innovations

By Chinmax Medical Systems Inc., PRNE
Sunday, March 7, 2010

SHANGHAI, March 8, 2010 - On January 28, 2010, Chinmax Medical Systems, Inc., a leading distributor
of clinical diagnostics in China, filed a civil complaint in the People's
Court of Yangpu District, Shanghai against Inverness Medical Beijing Co.
Ltd., a subsidiary of Inverness Medical Innovations, Inc. (NYSE: IMA).

According to the complaint, Chinmax is the exclusive distributor in China
of diagnostics products manufactured by Biosite Incorporated, a leading
cardiac biomarkers company in San Diego, California, USA. Biosite was
acquired by Inverness Medical Innovations, Inc. (NYSE: IMA) in June 2007.
The complaint accused Inverness Medical Beijing Co. Ltd., along with a second
defendant, Shanghai Tongwei Medical Device Co. Ltd., of infringing Chinmax's
exclusive distribution rights by importing and selling the relevant products
in China without permission. The complaint also accused Inverness Medical
Beijing of infringing Chinmax's proprietary rights to the relevant product
registrations issued by China's State Food and Drug Administration ("SFDA").

Chinmax is seeking from the court a cease and desist order prohibiting
the defendants from importing and selling the relevant products in China.
Chinmax is also asking the court to order Inverness Medical Beijing to return
the relevant product registration documents to Chinmax and stop infringing
acts before China's State Food and Drug Administration ("SFDA").

"We have invested too much in helping Biosite become the market leader in
China to allow the infringement of our rights," said Kevin Yue, President of
Chinmax. "We will vigorously protect our rights, and take necessary actions
against any infringers."

Chinmax has been distributing Biosite products for over 10 years since
1999, and the Biosite Triage products currently have more than 80% of the
heart failure diagnostics market share in China.

Mr. Kevin Yue, +86-139-0180-0687, Kevin at chinmax.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :